Jason Baum Leap Therapeutics, Inc. (LPTX) insider trading activity

LPTX Quotes by TradingView

Jason Baum is Chief Scientific Officer of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 15,896 shares of LPTX, which is worth approximately $5,722. The most recent transaction as insider was on Mar 28, 2025, when has been sold 6,604 shares (Common Stock) at a price of $0.32 per share, resulting in proceeds of $2,113. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.9K
n/a 3M change
n/a 12M change
Total Value Held $5,722

Jason Baum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2025
SELL
Payment of exercise price or tax liability
$2,113 $0.32 p/Share
6,604 Reduced 29.35%
15,896 Common Stock
Mar 28 2025
BUY
Exercise of conversion of derivative security
-
22,500 Added 50.0%
22,500 Common Stock
JB

Jason Baum

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on LPTX

Follow LEAP THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LPTX shares.

Notify only if

Insider Trading

Get notified when an Leap Therapeutics, Inc. insider buys or sells LPTX shares.

Notify only if

News

Receive news related to LEAP THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LPTX